Skip to main content
  1. Life
  2. Health & Fitness
  3. Holistic Health

FDA approves Tretten for those hot to clot

See also

The FDA has announced the approval of Tretten for basic prevention of bleeding in adults and children who have a rare clotting disorder, known as congenital Factor XIII, an extremely rare genetic disorder in which they do not produce enough of the protein Factor XIII needed for normal clotting.

“The approval of this product provides another therapeutic option for the prevention of bleeding in patients with Factor XIII A-subunit deficiency,” said Karen Midthun, M.D., director of the FDA’s Center for Biologics Evaluation and Research. “Without treatment, people with this rare condition are at risk of bleeding to death.”

According to clinical trials, Tretten was effective in preventing bleeding in 90% of the patients when given monthly, and did not cause anyone taking it to develop any abnormal clotting, according to Midthun. However, some of the participants did report headaches, and pain at injection site.

To learn more contact the FDA consumer line at 888-INFO-FDA

Advertisement

Life

  • Dead babies found
    Seven dead babies were found in Utah resident Megan Huntsman's old home
    Video
    Shocking Discovery
  • Kendall Jenner
    Get the Coachella looks: Kendall Jenner’s nose ring, green hair and edgy nails
    Camera
    Coachella Look
  • Dog's Easter basket
    How to fill your dog’s Easter basket with the perfect toys
    Easter Basket
  • Rabbit owners
    Bringing home the bunny: Important information for rabbit owners
    Camera
    7 Photos
  • Haunted island
    The world’s most haunted island may soon be the most haunted luxury resort
    Haunted Resort
  • Sunken ferry
    Search continues for missing passengers after a ferry sinks off the South Korean coast
    Video
    Sunken Ferry

User login

Log in
Sign in with your email and password. Or reset your password.
Write for us
Interested in becoming an Examiner and sharing your experience and passion? We're always looking for quality writers. Find out more about Examiner.com and apply today!